Demand for renal function tests will increase through 2036, with dipsticks at a 36.8% share in 2026 as the leading product type segment. The market was valued at USD 969.70 million in 2025 and is expected to reach USD 1840.78 million by 2036, creating an incremental opportunity of USD 812.90 million.